TASEKO MINES LTD (TGB)       1.77  -0.01 (-0.56%)

1.77  -0.01 (-0.56%)

CA8765111064 - Common Stock - After market: 1.79 +0.02 (+1.13%)


Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to TGB. TGB was compared to 980 industry peers in the Metals & Mining industry. Both the profitability and financial health of TGB have multiple concerns. While showing a medium growth rate, TGB is valued expensive at the moment.

Note: TGB has only limited data available, so a full analysis was not possible, which makes the total rating unfair.




Profitability

Profitability Rating

1

The Piotroski-F score of TGB is 3.00. This is a low score and indicates issues in the health and profitability of TGB.

VS Industry

Valuation

Valuation Rating

1

When comparing the current price to the book value of TGB, we can conclude it is valued correctly. It is trading at 1.90 times its book value.
When comparing the price book ratio of TGB to the average industry price book ratio of 1.72, TGB is valued in line with its industry peers.
With a Price/Earnings Ratio of 88.50, TGB can be considered very expensive at the moment.

Compared to an average industry Price/Earning Ratio of 12.12, TGB is valued more expensive than its industry peers. On top of this 98% of the companies listed in the same industry are cheaper than TGB!
The Forward Price/Earnings Ratio of 72.68 indicates a quite expensive current valuation of TGB.
Compared to an average industry Enterprise Value to EBITDA ratio of 5.85, TGB is valued more expensive than its industry peers.
VS Industry

Price/Earnings (88.5) VS Industry: 2% outperformed.

809.00
0.13

Price/Book (1.9) VS Industry: 45% outperformed.

520.28
0.03

Enterprise Value/ EBITDA (9.39) VS Industry: 34% outperformed.

1,081.43
0.38

Growth

Growth Rating

4

Based on estimates for the next 5 years, TGB will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.53% on average per year.
Measured over the past 5 years, TGB shows a quite strong growth in Revenue. The Revenue has been growing by 10.42% on average per year.
The Revenue has decreased by -5.67% in the past year.

Based on estimates for the next 5 years, TGB will show a small growth in Revenue. The Revenue will grow by 5.32% on average per year.
The earnings per share for TGB have decreased strongly by -66.67% in the last year.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A -66.67% -101.11% -56.11% -13.84% 13.53%
Revenue10.42% 8.01% -5.67% -11.86% -1.94% 1.27% 5.32%

Health

Health Rating

2

A Current Ratio of 2.28 indicates that TGB has no problem at all paying its short term obligations.
The Current Ratio is in line with the industry averages, which is at 2.63.
A Quick Ratio of 1.67 indicates that TGB should not have too much problems paying its short term obligations.
TGB has a Quick Ratio comparable to the industry average, which is at 2.24.

Compared to an average industry Debt to Equity Ratio of 0.00, TGB is requires more financing than its industry peers. 99% of its industry peers have a better Debt to Equity Ratio.
TGB has an Altman-Z score of 0.85. This is a bad value and indicates that TGB is not financially healthy and even has some risk of bankruptcy.
Compared to an average industry Altman-Z score of 2.69, TGB is in worse financial health than its industry peers.
TGB has a quite weak Piotroski-F score of 3.00. This indicates issues in the health and profitability of TGB.
VS Industry

Debt/Equity (1.53) VS Industry: 1% outperformed.

4.83
0.00

Quick Ratio (1.67) VS Industry: 42% outperformed.

0.00
211.92

Current Ratio (2.28) VS Industry: 45% outperformed.

0.00
211.92

Altman-Z (0.85) VS Industry: 36% outperformed.

-22,403.48
2,115.39

Dividend

Dividend Rating

0

No dividends for TGB!.

TASEKO MINES LTD1.77

NYSEARCA:TGB (1/31/2023, 7:04:00 PM)-0.01 (-0.56%)

After market: 1.79 +0.02 (+1.13%)

Chartmill FA Rating
GICS Sector Materials
GICS IndustryGroup Materials
GICS Industry Metals & Mining
Earnings (Last) 11-03 2022-11-03/amc Earnings (Next) 02-20 2023-02-20
Inst Owners 19.36% Inst Owner Change 0.01%
Ins Owners N/A Ins Owner Change N/A
Market Cap 506.93M Analysts 80
Price Target 1.94 (9.6%)

Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A

Surprises & Revisions
EPS beat(2) 1 Avg EPS beat(2) -544.55%
Min EPS beat(2) -1288.12% Max EPS beat(2) 199.01%
EPS beat(4) 1 Avg EPS beat(4) -284.98%
Min EPS beat(4) -1288.12% Max EPS beat(4) 199.01%
Revenue beat(2) N/A Avg Revenue beat(2) -9.88%
Min Revenue beat(2) -16.72% Max Revenue beat(2) -3.04%
Revenue beat(4) N/A Avg Revenue beat(4) -10.1%
Min Revenue beat(4) -16.72% Max Revenue beat(4) -3.04%
PT rev (1m) 9.53% EPS NQ rev (1m) 0%
EPS NY rev (1m) 0% Revenue NQ rev (1m) 0%
Revenue NY rev (1m) 0%

Valuation
Industry RankSector Rank
PE 88.5
Fwd PE 72.68
P/S 1.73
P/FCF 82.03
P/OCF 5.71
P/B 1.9
P/tB 1.93
EV/EBITDA 9.39
EPS(TTM) 0.02 EY 1.13%
EPS(NY) 0.02 Fwd EY 1.38%
FCF(TTM) 0.02 FCFY 1.22%
OCF(TTM) 0.31 OCFY 17.52%
SpS 1.02 BVpS 0.93
TBVpS 0.92 PEG (NY) N/A
PEG (5Y) N/A

Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC 4.17%
ROICexc 4.78%
ROICexgc 4.81%
OM 15.03%
PM N/A
GM 18.39%
ROICexgc(3y) N/A ROICexcg growth 3Y 73.04%
ROICexcg growth 5Y N/A ROICexc(3y) N/A
ROICexc growth 3Y 73.06% ROICexc growth 5Y N/A
OM growth 3Y 58.6% OM growth 5Y N/A
PM growth 3Y N/A PM growth 5Y N/A
GM growth 3Y 46.68% GM growth 5Y 123.23%
F-Score 3 Asset Turnover 0.32

Health
Industry RankSector Rank
Debt/Equity 1.53
Debt/FCF 67.85
Debt/EBITDA 4.81
Cap/Depr 191.48%
Profit Quality N/A
Current Ratio 2.28
Quick Ratio 1.67
Altman-Z 0.85
F-Score 3 WACC 10.55%
ROIC/WACC 0.46 Cap/Depr(3y) 73.74%
Cap/Depr(5y) 111.81% Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y -66.67% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q -80%
EPS Next Y -101.11% EPS Next 2Y -56.11%
EPS Next 3Y -13.84% EPS Next 5Y 13.53%
Revenue growth 1Y -5.67% Revenue growth 3Y 8.01%
Revenue growth 5Y 10.42% Revenue growth Q2Q -32.32%
Revenue Next Year -11.86% Revenue Next 2Y -1.94%
Revenue Next 3Y 1.27% Revenue Next 5Y 5.32%
EBIT growth 1Y -42.78% EBIT growth 3Y 71.3%
EBIT growth 5Y N/A EBIT Next Year -26.97%
EBIT Next 3Y 4.85% EBIT Next 5Y 13.78%
FCF growth 1Y -74.96% FCF growth 3Y N/A
FCF growth 5Y 47.11% OCF growth 1Y 25.73%
OCF growth 3Y 22.92% OCF growth 5Y 38.82%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA